Åsmund Ragnar Reikvam (born 1944 in Førde) is a Norwegian professor in medicine and former politician.
[2] Before moving to Oslo he was a member of Førde municipality council for eight years, representing the Labour Party.
He has been a member of the steering committees of important clinical trials, including the International Studies of Infarct Survival, ISIS2, ISIS3, ISIS4, and the EU funded trials of the European Secondary Prevention Study Group and, furthermore, a national co-ordinator of HOPE and GUARDIAN.
In recent years his main scientific interest has been pharmacotherapy and pharmacoepidemiology of cardiovascular diseases, particularly management of myocardial infarction.
He has been a member of EMEA's (European Medicines Agency) pharmacovigilance working party and has had health care evaluation assignments for OECD.